相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TAK1 control of cell death
S. R. Mihaly et al.
CELL DEATH AND DIFFERENTIATION (2014)
MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition
H. Rajabi et al.
ONCOGENE (2014)
Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling
Patty C. H. Cai et al.
ONCOTARGET (2014)
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Ryan B. Corcoran et al.
CANCER CELL (2013)
MUC1-C Oncoprotein Activates ERK→C/EBPβ Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells
Maroof Alam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
D. W. Kufe
ONCOGENE (2013)
Cell type-specific function of TAK1 in innate immune signaling
Adebusola A. Ajibade et al.
TRENDS IN IMMUNOLOGY (2013)
Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis
D. M. Ray et al.
BRITISH JOURNAL OF CANCER (2012)
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Anurag Singh et al.
CELL (2012)
MUC1-C Oncoprotein Induces TCF7L2 Transcription Factor Activation and Promotes Cyclin D1 Expression in Human Breast Cancer Cells
Hasan Rajabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species
Emily Omori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeting of TAK1 in inflammatory disorders and cancer
Hiroaki Sakurai
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Importance and regulation of the colonic mucus barrier in a mouse model of colitis
J. Petersson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Molecular Genetics of Colorectal Cancer
Eric R. Fearon
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Intestinal Inflammation and Cancer
Thomas A. Ullman et al.
GASTROENTEROLOGY (2011)
A Monoclonal Antibody Against the Oncogenic Mucin 1 Cytoplasmic Domain
Govind Panchamoorthy et al.
HYBRIDOMA (2011)
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer
Daniel T. Starczynowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Dependence on the MUC1-C Oncoprotein in Non-Small Cell Lung Cancer Cells
Deepak Raina et al.
MOLECULAR CANCER THERAPEUTICS (2011)
MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop
Rehan Ahmad et al.
SCIENCE SIGNALING (2011)
Ablation of TAK1 Upregulates Reactive Oxygen Species and Selectively Kills Tumor Cells
Emily Omori et al.
CANCER RESEARCH (2010)
Aberrant Expression of MUC1 Mucin in Pediatric Inflammatory Bowel Disease
Anna E. Furr et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2010)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription Factor
Rehan Ahmad et al.
CANCER RESEARCH (2009)
MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer
Nikolai N. Khodarev et al.
CANCER RESEARCH (2009)
Two Mechanistically and Temporally Distinct NF-κB Activation Pathways in IL-1 Signaling
Kohsuke Yamazaki et al.
SCIENCE SIGNALING (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
MUC1 and colorectal cancer pathophysiology considerations
Yaron Niv
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling
Rehan Ahmad et al.
NATURE CELL BIOLOGY (2007)
MUC1 cell surface mucin is a critical element of the mucosal barrier to infection
Julie L. McAuley et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cutting edge:: Transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer
Pamela L. Beatty et al.
JOURNAL OF IMMUNOLOGY (2007)
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status
A. Lugli et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
MUC genes are differently expressed during onset,and maintenance of inflammation in dextran sodium sulfate-treated mice
C Hoebler et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
MUC1 oncoprotein blocks glycogen synthase kinase 3β-mediated phosphorylation and degradation of β-catenin
L Huang et al.
CANCER RESEARCH (2005)
Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking
QB Wang et al.
MOLECULAR CELL (2005)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma
H Suzuki et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Mucins and mucin binding proteins in colorectal cancer
JC Byrd et al.
CANCER AND METASTASIS REVIEWS (2004)
15-Deoxy-Δ12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts
B Relic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts
D Raina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Human DF3/MUC1 carcinoma-associated protein functions as an oncogene
YQ Li et al.
ONCOGENE (2003)
TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway
G Takaesu et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewisa and sialyl-Lewisx antigens in colorectal adenocarcinoma
SE Baldus et al.
HISTOPATHOLOGY (2002)
Altered glycosylation in inflammatory bowel disease: A possible role in cancer development
BJ Campbell et al.
GLYCOCONJUGATE JOURNAL (2001)
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
C Wang et al.
NATURE (2001)
分享论文
